] India, a major source of inexpensive AIDS drugs, passed a
] new patent law yesterday that groups providing drugs to
] the world's poorest patients fear will choke off their
] supply of new treatments.

Lessig has alleged before that the problem here isn't the drug companies but rather the US Congress: the drug companies are happy to charge Indians $20/year for drugs that cost $20k/year in the US -- but congress won't stand for such price discrimination.